JOHNSON & JOHNSON PP&E Net 2008-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current pp&e net?
JOHNSON & JOHNSON (JNJ) annual pp&e net for 2025 was $23.17B, a 12.92% increase from 2024. JOHNSON & JOHNSON pp&e net for the quarter ending March 29, 2026 was $23.27B.
What was JOHNSON & JOHNSON's pp&e net in 2024?
JOHNSON & JOHNSON annual pp&e net for 2024 was $20.52B, a 3.12% increase from 2023.
What was JOHNSON & JOHNSON's pp&e net in 2023?
JOHNSON & JOHNSON annual pp&e net for 2023 was $19.90B, a 4.94% increase from 2022.
What is JOHNSON & JOHNSON's 4-year pp&e net CAGR?
JOHNSON & JOHNSON pp&e net grew at a compound annual growth rate (CAGR) of 5.41% from FY2021 to FY2025, going from $18.77B to $23.17B over 4 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+5.6%
FY2019
$17.66B
→
FY2025
$23.17B
081011121314161718192122232425
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $23.17B | +12.9% | 10-K |
| FY2024 | $20.52B | +3.1% | 10-K |
| FY2023 | $19.90B | +4.9% | 10-K |
| FY2022 | $18.96B | +1.0% | 10-K |
| FY2021 | $18.77B | +6.3% | 10-K |
| FY2019 | $17.66B | +3.7% | 10-K |
| FY2018 | $17.04B | +0.2% | 10-K |
| FY2017 | $17.00B | +6.9% | 10-K |
| FY2016 | $15.90B | -1.4% | 10-K |
| FY2014 | $16.13B | -3.5% | 10-K |
| FY2013 | $16.71B | +13.4% | 10-K |
| FY2012 | $14.74B | +1.3% | 10-K |
| FY2011 | $14.55B | -1.4% | 10-K |
| FY2010 | $14.76B | +2.7% | 10-K |
| FY2008 | $14.37B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →